His
knowledge of molecular imaging — a new field that he had learned in his corporate experience — proved to be extremely valuable to his new institution.
Nuclear medicine — a vital component of the rapidly emerging
field of molecular imaging — is a medical specialty that uses small amounts of radioactive materials bound to special compounds (radiopharmaceuticals) in combination with imaging instrumentation that examine molecular processes in the body to detect and evaluate disease, such as brain disorders, heart disease and cancer.
Xiaoyuan Chen, Ph.D., Chief of the
Laboratory of Molecular Imaging and Nanomedicine at NIBIB, and his team attempted to solve this problem by developing a radiotracer that could identify prostate cancer at all stages.
«Experts call for expansion
of molecular imaging in precision cancer care: The noninvasive approach needs more research but carries added benefits to biopsies, they say.»
Established in 1972 by Charles Todd, City of Hope's
Department of Molecular Imaging & Therapy began at a time in which immune - based strategies for cancer were in their infancy.
The results were originally published in Nuclear Medicine Communications, International
Journal of Molecular Imaging, and Annals of Nuclear Medicine.
«This technology allows us to obtain in - depth knowledge
of molecular imaging techniques, how to optimize them, and how to leverage data with statistical analysis while advancing new radiotracers and contrast agents for the imaging and treatment of a range of diseases,» said Zhen Liu, PhD candidate and lead author of the study from the department of nuclear medicine at Technical University Munich, in Munich, Germany.
Paulsen's study investigated whether the
addition of molecular imaging (NIRST) at the time of MRI would improve the diagnostic accuracy of breast MRI alone by contributing functional information about regions of suspicion in the breast identified by the MRI and helping to categorize the regions as malignant or benign.
Lead author Alexander Neumeister, MD,
director of the molecular imaging program in the Departments of Psychiatry and Radiology at NYU School of Medicine, and colleagues are the first to demonstrate through brain imaging that people with PTSD have markedly lower concentrations of at least one of these neurotransmitters — an endocannabinoid known as anandamide — than people without PTSD.
Patrick McConville, Ph.D., is chief operating officer, chief scientific officer, and a
co-founder of Molecular Imaging Inc., the only contract research organization (CRO) dedicated to in vivo preclinical imaging.
The Clinical Trials Network (CTN) provides tools and resources to promote faster, more cost - effective drug development and increase the availability and
performance of molecular imaging radiopharmaceuticals for use in the clinic.
Our Mission is to advance the
use of molecular imaging agents in clinical trials through standardization of chemistry and imaging methodology.
Available to physicians, scientists or pharmacists possessing an advanced degree who have presented credentials indicating their professional activity, either, medical, paramedical, investigational or educational in the scientific or clinical
disciplines of molecular imaging or nuclear medicine.
An award of $ 82,500 over roughly nine months bolstered Kuang's research, which aims to determine which
combination of molecular imaging and biomarkers can provide early insight into a patient's response to chemotherapy.
«Although treatable at the early stage, prostate cancer is prone to metastasis,» explain the team of authors, led by Xiaoyuan Chen, senior investigator,
Laboratory of Molecular Imaging and Nanomedicine at the U.S. National Institute of Biomedical Imaging and Bioengineering.
Today, the
Department of Molecular Imaging & Therapy continues to advance original vision, focusing simultaneously on immunology and on structural biology.
Theranostics is a multidisciplinary journal that publishes innovative and original research papers reflecting the field
of molecular imaging, molecular therapeutics, multifunctional nanoparticle platforms, image - guided therapy, and translational nanomedicine.
Bhujwalla also has received the Gold Medal Award from the World Molecular Imaging Society — the highest award given at the World Molecular Imaging Congress — for her outstanding contributions to the field
of molecular imaging.